During the past decade, Sacred Heart Medical Oncology Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacred Heart Medical Oncology Group" #1 sponsor was "Celgene" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Medical Oncology Group" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sacred Heart Medical Oncology Group" are "Lung Cancer" (3 trials), "Multiple Myeloma" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Sacred Heart Medical Oncology Group" in a lesser frequency.

Most popular intervention types in "Sacred Heart Medical Oncology Group" are "Drug" (6 trials), "Biological" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMG 510" (1 trials), "Amrubicin" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sacred Heart Medical Oncology Group" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Sacred Heart Medical Oncology Group". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sacred Heart Medical Oncology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sacred Heart Medical Oncology Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".